文献速递术前评估与围术期医学疼痛医学

成人术后慢性疼痛预防的药物治疗:更新系统综述与荟萃分析

Pharmacotherapy for the Prevention of Chronic Pain after Surgery in Adults: An Updated Systematic Review and Meta-analysis.
PubMed 文献 · Anesthesiology · 2021-01-01

该系统综述更新评估了围术期全身用药预防成人术后慢性疼痛的效果,纳入双盲安慰剂对照随机试验。共识别70项新研究和2013年的40项研究,多数评估氯胺酮、普瑞巴林、加巴喷丁、静脉利多卡因、非甾体抗炎药和糖皮质激素。部分荟萃分析显示普瑞巴林、静脉利多卡因和非甾体抗炎药可降低慢性术后疼痛患病率,但临床相关性不明确;氯胺酮和普瑞巴林(用药超过24小时)对任何疼痛无显著效果,普瑞巴林对中重度疼痛有显著效果但证据需谨慎解读。

要点

  • 普瑞巴林、静脉利多卡因和非甾体抗炎药可能降低慢性术后疼痛患病率,但临床相关性不明确。
  • 氯胺酮用药≤24小时或>24小时对6个月任何疼痛均无显著效果。
  • 普瑞巴林用药>24小时对3个月任何疼痛无显著效果,但对3个月中重度疼痛有显著效果。

核心结论

  • 尽管术后慢性疼痛是重要议题,但自2013年以来进展甚微,可能因研究设计不足以解决该多因素问题的复杂性。

研究设计与样本

  • 系统综述与荟萃分析,纳入双盲、安慰剂对照的随机对照试验,研究对象为成人,评估围术期全身用药。
  • 识别70项新研究和2013年的40项研究,评估药物包括氯胺酮、普瑞巴林、加巴喷丁、静脉利多卡因、非甾体抗炎药和糖皮质激素。
  • 主要结局为术后3个月或更长时间报告任何疼痛的比例。

主要发现

  • 部分荟萃分析显示普瑞巴林、静脉利多卡因和非甾体抗炎药治疗后慢性术后疼痛患病率有统计学显著降低,但临床相关性不明确。
  • 氯胺酮用药≤24小时对6个月任何疼痛无显著效果(风险比0.62 [95%CI 0.36-1.07];患病率氯胺酮0-88%,安慰剂0-94%)。
  • 氯胺酮用药>24小时对6个月任何疼痛无显著效果(风险比0.91 [95%CI 0.74-1.12];患病率氯胺酮6-71%,安慰剂5-78%)。
  • 普瑞巴林用药>24小时对3个月任何疼痛无显著效果(风险比0.88 [95%CI 0.70-1.10];患病率普瑞巴林4-88%,安慰剂3-80%)。
  • 普瑞巴林用药>24小时对6个月任何疼痛无显著效果(风险比0.78 [95%CI 0.47-1.28];患病率普瑞巴林6-68%,安慰剂4-69%)。

关键数值与推荐

  • 荟萃分析纳入超过3项研究且超过500名参与者时,氯胺酮用药≤24小时对6个月任何疼痛风险比0.62(95%CI 0.36-1.07)。
  • 氯胺酮用药>24小时对6个月任何疼痛风险比0.91(95%CI 0.74-1.12)。
  • 普瑞巴林用药>24小时对3个月任何疼痛风险比0.88(95%CI 0.70-1.10)。
  • 普瑞巴林用药>24小时对6个月任何疼痛风险比0.78(95%CI 0.47-1.28)。
  • 普瑞巴林用药>24小时对3个月中重度疼痛风险比0.47(95%CI 0.33-0.68)。

临床怎么用

  • 普瑞巴林、静脉利多卡因和非甾体抗炎药可能降低慢性术后疼痛患病率,但临床相关性不明确,需结合患者情况谨慎使用。
  • 氯胺酮对6个月任何疼痛无显著预防效果,不推荐常规用于预防慢性术后疼痛。
  • 普瑞巴林用药超过24小时可能减少3个月中重度疼痛,但结果需谨慎解读。

局限性

  • 研究规模小,手术类型、剂量、给药时机和结局测量方法变异大,且与急性疼痛轨迹和术前疼痛状态相关。
  • 结果应谨慎解读,因研究设计不足以解决术后慢性疼痛的多因素复杂性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Chronic postsurgical pain can severely impair patient health and quality of life. This systematic review update evaluated the effectiveness of systemic drugs to prevent chronic postsurgical pain. METHODS: The authors included double-blind, placebo-controlled, randomized controlled trials including adults that evaluated perioperative systemic drugs. Studies that evaluated same drug(s) administered similarly were pooled. The primary outcome was the proportion reporting any pain at 3 or more months postsurgery. RESULTS: The authors identified 70 new studies and 40 from 2013. Most evaluated ketamine, pregabalin, gabapentin, IV lidocaine, nonsteroidal anti-inflammatory drugs, and corticosteroids. Some meta-analyses showed statistically significant-but of unclear clinical relevance-reductions in chronic postsurgical pain prevalence after treatment with pregabalin, IV lidocaine, and nonsteroidal anti-inflammatory drugs. Meta-analyses with more than three studies and more than 500 participants showed no effect of ketamine on prevalence of any pain at 6 months when administered for 24 h or less (risk ratio, 0.62 [95% CI, 0.36 to 1.07]; prevalence, 0 to 88% ketamine; 0 to 94% placebo) or more than 24 h (risk ratio, 0.91 [95% CI, 0.74 to 1.12]; 6 to 71% ketamine; 5 to 78% placebo), no effect of pregabalin on prevalence of any pain at 3 months (risk ratio, 0.88 [95% CI, 0.70 to 1.10]; 4 to 88% pregabalin; 3 to 80% placebo) or 6 months (risk ratio, 0.78 [95% CI, 0.47 to 1.28]; 6 to 68% pregabalin; 4 to 69% placebo) when administered more than 24 h, and an effect of pregabalin on prevalence of moderate/severe pain at 3 months when administered more than 24 h (risk ratio, 0.47 [95% CI, 0.33 to 0.68]; 0 to 20% pregabalin; 4 to 34% placebo). However, the results should be interpreted with caution given small study sizes, variable surgical types, dosages, timing and method of outcome measurements in relation to the acute pain trajectory in question, and preoperative pain status. CONCLUSIONS: Despite agreement that chronic postsurgical pain is an important topic, extremely little progress has been made since 2013, likely due to study designs being insufficient to address the complexities of this multifactorial problem.

来源:Anesthesiology,查看原文。版权归原作者所有。

引用

  1. Carley ME, Chaparro LE, Choinière M, et al. Pharmacotherapy for the Prevention of Chronic Pain after Surgery in Adults: An Updated Systematic Review and Meta-analysis. Anesthesiology. 2021. PMID: 34237128. doi:10.1097/ALN.0000000000003837

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。